PB 108 of 2021
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2021
I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following determination.
Dated 17 September 2021
Nikolai Tsyganov
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021
(1) This instrument is the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2021.
(2) This instrument may also be cited as PB 108 of 2021.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 18 September 2021. | 18 September 2021 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 89A(3) of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
1 Subsection 5(8) (at the end of the table)
Add:
5 | Listed drug: Isosorbide mononitrate Form: Tablet 120 mg (sustained release) Manner of administration: Oral Brand: either of the following: (a) Imdur 120 mg; (b) Monodur 120 mg | Listed drug: Isosorbide mononitrate Form: Tablet 60 mg (sustained release) Manner of administration: Oral Brand: any of the following: (a) APO‑Isosorbide Mononitrate; (b) Duride; (c) GenRx Isosorbide Mononitrate; (d) Imdur Durule; (e) ISOBIDE MR; (f) Isomonit; (g) Isosorbide AN; (h) Monodur 60 mg |